Skip to main content

Month: August 2023

Global Urinalysis Market Size to Reach USD 6.49 Billion 2030 | Emergen Research

Growing prevalence of Urinary Tract Infection (UTIs), liver & kidney diseases, and diabetes is a significant factor driving global urinalysis market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — The anticipated expansion of the global urinalysis market is projected to reach a valuation of approximately USD 6.49 Billion by the year 2030. This growth is forecasted to occur at a consistent and moderate Compound Annual Growth Rate (CAGR) of 7.2%, as outlined in the latest analysis conducted by Emergen Research. The driving forces behind this market growth are multifaceted. There is an increasing prevalence of conditions such as Urinary Tract Infections (UTIs), diabetes, and various kidney diseases including Chronic Kidney Disease (CKD), polycystic kidney disease, and acute kidney failure. This escalation in health...

Continue reading

Smart Share Global Limited Announces Second Quarter 2023 Results

Net income reached RMB24.5 million for the second quarter of 2023POIs1 operated under network partner model reached 62.0% as of the end of the second quarter of 2023Number of POIs reached 1.1 million as of the end of the second quarter of 2023 SHANGHAI, China, Aug. 21, 2023 (GLOBE NEWSWIRE) — Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced its unaudited financial results for the quarter ended June 30, 2023. HIGHLIGHTS FOR THE SECOND QUARTER OF 2023Net income for the second quarter of 2023 was RMB24.5 million, compared to a net loss of RMB184.5 million in the same period last year. As of June 30, 2023, the Company’s services were available in 1,109 thousand POIs, compared with 1,001 thousand as of March 31, 2023. As of...

Continue reading

Global Sleep Apnea Devices Market Size to Reach USD 12.88 Billion 2030 | Emergen Research

Increasing number of companies venturing into sleep apnea devices in addition to the oral applications industry is a significant factor driving global sleep apnea devices market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — Anticipated to attain a value of USD 12.88 billion by 2030, the global market for sleep apnea devices is poised to grow steadily with a compound annual growth rate (CAGR) of 6.9%, as per the latest analysis conducted by Emergen Research. This growth is primarily propelled by the expanding patient cohort characterized by undiagnosed sleep apnea cases. Notably, Obstructive Sleep Apnea (OSA) stands as the most prevalent form of sleep-disordered breathing, affecting around 37% of men and 50% of women. However, a staggering 80% of individuals grappling with OSA remain undiagnosed, hence devoid of treatment. It’s...

Continue reading

Permian Resources to Acquire Earthstone Energy in All-Stock Transaction, Creating a $14 Billion Premier Delaware Basin Independent E&P

MIDLAND, Texas and THE WOODLANDS, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) — Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) and Earthstone Energy, Inc. (“Earthstone Energy” or “Earthstone”) (NYSE: ESTE) today announced that they have entered into a definitive agreement under which Permian Resources will acquire Earthstone in an all-stock transaction valued at approximately $4.5 billion, inclusive of Earthstone’s net debt. Under the terms of the transaction, each share of Earthstone common stock will be exchanged for a fixed ratio of 1.446 shares of Permian Resources common stock. The transaction strengthens Permian Resources’ position as a leading Delaware Basin independent E&P with over 400,000 Permian net acres, pro forma production of approximately 300,000 Boe/d1 and an enhanced free cash flow...

Continue reading

Global Allergy Diagnostics Market Size to Reach USD 12.45 Billion 2030 | Emergen Research

High prevalence of allergic diseases is a significant factor driving the global allergy diagnostics market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — The latest analysis by Emergen Research anticipates that the global market for allergy diagnostics is poised to attain a noteworthy valuation of USD 12.45 Billion by 2030, exhibiting a consistent compound annual growth rate (CAGR) of 11.1% in terms of revenue. A primary catalyst steering the augmented revenue generation within this market is the notable upsurge in the prevalence of allergic ailments. For instance, allergic rhinitis, commonly referred to as hay fever, affects approximately 7.8% of the populace in the United States. Furthermore, statistics suggest that Immunoglobulin E (IgE)-mediated food allergies or sensitivities afflict around 3.5-4% of the general...

Continue reading

Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing

PONTE VEDRA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ Procedure, today announced Nathan Minnich has been appointed Sr. Vice President, Marketing, effective immediately. In this new position, Mr. Minnich will lead all aspects of Treace’s marketing efforts, with a focus on expanding the Company’s physician outreach, patient awareness and market penetration efforts.  “I am delighted to welcome Nathan to the Treace team,” said John T. Treace, CEO, Founder and Board Member of Treace. “During his career, Nathan has led the development, implementation and execution of successful marketing...

Continue reading

Copper Road Resources Commences Summer 2023 Diamond Drilling Program in Batchewana Bay, Ontario

Figure 1Figure 1. JR Zone MM Lines and Proposed DDHsFigure 2Figure 2. JR Zone Long SectionFigure 3Figure 3. JR Zone Gradient IPTORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) — Copper Road Resources Inc. (TSXV: CRD) (“Copper Road” or the “Company”) is pleased to announce that the 2023 drill program has commenced at the highly-prospective JR Zone at its Copper Road Project in Batchewana Bay, Ontario. The current drill campaign is designed to demonstrate that the JR Zone hosts a shallow mineralized porphyry and high-grade breccia in the centre of the Company’s district-scale land package that hosts two past-producing copper mines. The JR Zone, comprising the Jogran Porphyry and nearby Richards Breccia (see Figure 1), is located approximately 12 km from the former Tribag Mine Zone which the Company drilled in 2022...

Continue reading

Agrify Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on August 16, 2023, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that it was not in compliance with requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, with the Securities and Exchange Commission (“SEC”). This notification has no immediate effect on the listing of Agrify’s common stock on the Nasdaq. However, if Agrify fails to timely regain compliance with the Nasdaq Listing Rule, Agrify’s common stock will be subject...

Continue reading

FuelPositive Seeks Approval for Warrant Repricing

WATERLOO, Ontario, Aug. 21, 2023 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB:NHHHF) (the “Company”), a leading Green Ammonia company, announces that it has applied to the TSX Venture Exchange to amend (the “Amendment”) the terms of a series of 8,249,823 share purchase warrants (collectively, the “Warrants”). The Warrants are currently exercisable at a price of $0.34, with 3,044,000 expiring on August 21, 2023, and 5,205,823 expiring on September 5, 2023. Under the terms of the Amendment, the exercise price of the Warrants would be reduced to $0.06. As an additional incentive to encourage the exercise of the Warrants, upon exercise of each Warrant, the holder would be entitled to receive one common share and one additional share purchase warrant (each, an “Incentive Warrant”). Each Incentive Warrant will be...

Continue reading

GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine

STAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG) has published a peer-reviewed research analysis resulting from a multi-lab collaboration involving GeneDx. The study, “The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change,” evaluated the rate of inconclusive genetic variants, or variants of uncertain significance (VUS), reported with multi-gene panels versus exome and genome sequencing. Study findings concluded that VUS are reported more frequently on multi-gene panels (32.6%) than exome and genome sequencing (22.5%). “The high rates of VUS found with multi-gene panel tests...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.